Business of the House

Peter Bone Excerpts

Thursday 9th January 2014 Commons Chamber

[Mr Lansley]

The hon. Gentleman will know that both my right hon. Friends the Secretary of State for Work and Pensions and the Prime Minister have repeatedly responded to questions about food banks, as we will continue to do. For my part, I know, having visited a food bank, the value of food banks’ work. It is important to recognise that, and we have supported them. That is why, when my right hon. Friend the Secretary of State came into office, he changed the decision of the previous Government not to refer people from jobcentres to food banks.

[Mr Peter Bone (Wellingborough) (Con)]

In February 2009, Zac Knighton-Smith, who was five, was diagnosed with neuroblastoma and given only a few weeks to live without a new monoclonal antibody therapy. That treatment was not available on the NHS, but thanks to the efforts of the former health Minister Ann Keen, John Parkes of Northamptonshire primary care trust and the then shadow Secretary of State for Health—the Leader of the House—Zac received the treatment in Germany, which the NHS paid for. On Saturday, this lovely, full-of-life and happy little boy passed away. He will be sadly and greatly missed. However, without politicians of different parties working together, he would not have had the last five years of life. May we have a statement on how this Parliament can make a difference?

[Mr Lansley]

I am grateful to my hon. Friend for his question. I recall the case to which he refers, and he is absolutely right that we in this House can make a difference, not least by working together, but especially where Members of Parliament pursue their constituents’ cases and concerns. I pay tribute to the way in which he did so on behalf of Zac’s family.

We can also make a difference by the policies we bring forward. In that respect, I am proud that as Secretary of State for Health in this Parliament I was able to introduce the cancer drugs fund, which has delivered treatments to 38,000 patients. We also decided to undertake investment in the delivery of proton beam therapy in this country, because the only way patients could otherwise access that treatment was by going to Germany.